Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,971Revenue $M10,235Net Margin (%)15.6Z-Score3.6
Enterprise Value $M48,156EPS $3.6Operating Margin %18.7F-Score8
P/E(ttm))27.2Cash Flow Per Share $5.3Pre-tax Margin (%)17.1Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %8.0Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %2.0Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow11.0y-y EBITDA Growth Rate %-8.3ROA % (ttm)8.2Higher Current Ratio y-yN
Dividend Yield %1.3Insider Buy (3m)2ROE % (ttm)17.2Less Shares Outstanding y-yY
Payout Ratio %45.0Shares Outstanding M452ROI % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with COV

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVDavid Abrams 2014-09-30 Buy 13.4%$82.54 - $91.76
($88.57)
$ 99.3212%New holding, 2620000 sh.2,620,000
COVJohn Paulson 2014-09-30 Add2%$82.54 - $91.76
($88.57)
$ 99.3212%Add 79.93%12,595,000
COVPrivate Capital 2014-09-30 Reduce-0.85%$82.54 - $91.76
($88.57)
$ 99.3212%Reduce -33.88%157,828
COVGeorge Soros 2014-09-30 Sold Out -0.15%$82.54 - $91.76
($88.57)
$ 99.3212%Sold Out0
COVMario Gabelli 2014-09-30 Reduce-0.08%$82.54 - $91.76
($88.57)
$ 99.3212%Reduce -27.49%462,251
COVJohn Paulson 2014-06-30 Buy 2.7%$69.03 - $91.24
($74.56)
$ 99.3233%New holding, 7000000 sh.7,000,000
COVGeorge Soros 2014-06-30 Buy 0.15%$69.03 - $91.24
($74.56)
$ 99.3233%New holding, 227000 sh.227,000
COVJoel Greenblatt 2014-06-30 Sold Out $69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVBill Nygren 2014-06-30 Reduce-1.51%$69.03 - $91.24
($74.56)
$ 99.3233%Reduce -94.09%160,000
COVRobert Olstein 2014-06-30 Sold Out -0.95%$69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVDonald Yacktman 2014-06-30 Sold Out -0.55%$69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVRay Dalio 2014-06-30 Sold Out -0.03%$69.03 - $91.24
($74.56)
$ 99.3233%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 99.3243%New holding, 3746 sh.3,746
COVRay Dalio 2014-03-31 Reduce-0.02%$66.35 - $72.5
($69.62)
$ 99.3243%Reduce -41.8%47,058
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 99.3253%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 99.3253%New holding, 80858 sh.80,858
COVPrivate Capital 2013-12-31 Reduce-0.8%$59.82 - $68.42
($65.08)
$ 99.3253%Reduce -36.57%244,555
COVHOTCHKIS & WILEY 2013-12-31 Reduce-0.16%$59.82 - $68.42
($65.08)
$ 99.3253%Reduce -46.79%657,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV David Abrams 2014-09-302,620,0000.5813.4New Buy
COV John Paulson 2014-09-3012,595,0002.794.5+79.93%
COV Jean-Marie Eveillard 2014-09-301,50000
COV Ronald Muhlenkamp 2014-09-30182,1800.042.8
COV Vanguard Health Care Fund 2014-09-304,994,7001.111.1
COV Bill Nygren 2014-09-30160,0000.040.09
COV John Keeley 2014-09-3040,8400.010.07
COV Dodge & Cox 2014-09-3089,0170.020.01-3.26%
COV HOTCHKIS & WILEY 2014-09-30727,7000.160.23-7.73%
COV Mario Gabelli 2014-09-30462,2510.10.22-27.49%
COV Private Capital 2014-09-30157,8280.031.6-33.88%
COV George Soros 2014-09-30000Sold Out
COV Bill Nygren 2014-06-30160,0000.040.1-94.09%
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROWN RICHARD G JRVice President and Controller 2014-11-17Buy5,300$94.444.52view
Lannum Coleman N IIIVice President 2014-11-14Buy821$93.535.54view
Clemmer James CSenior Vice President 2014-11-10Sell3,464$92.486.74view
BRUST ROBERT HDirector 2014-11-07Sell4,000$92.037.26view
Lannum Coleman N IIIVice President 2014-08-27Buy3,338$87.2313.16view
Lannum Coleman N IIIVice President 2014-08-26Buy1,736$87.4612.86view
Lannum Coleman N IIIVice President 2014-08-19Buy1,720$87.8212.4view
BROWN RICHARD G JRVice President and Controller 2014-08-18Buy2,000$87.6912.57view
Lannum Coleman N IIIVice President 2014-08-18Buy4,100$87.5812.71view
ALMEIDA JOSE EPresident and Chief Executive 2014-06-16Sell51,166$92.057.24view

Press Releases about COV :

Quarterly/Annual Reports about COV:

News about COV:

Articles On GuruFocus.com
Dividend Aristocrats In Focus Part 44: Medtronic Nov 23 2014 
Third Avenue's Top Stocks as of Q3 Nov 16 2014 
Medical Technology Company Offers Investment Opportunity Sep 25 2014 
Gabelli Value 25 Fund Second Quarter Commentary Sep 15 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Abbott: A Brighter Future Aug 28 2014 
A Strong Candidate for Investor´s Portfolios Aug 12 2014 
The Gabelli Equity Income Fund Second Quarter 2014 Shareholder Commentary Jul 25 2014 
Steven Romick's Top Five Stocks Jul 11 2014 
American Water Works - Nice Steady Upward Jun 21 2014 

More From Other Websites
Covidien's Bedside Patient Monitoring System Gets CE Mark Nov 24 2014
Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus Nov 21 2014
Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus Nov 21 2014
Covidien Announces Mailing of Definitive Joint Proxy Statement/Prospectus Nov 21 2014
COVIDIEN PLC Files SEC form 8-K, Regulation FD Disclosure Nov 21 2014
Covidien Achieves CE Mark for the Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N Nov 20 2014
Covidien Achieves CE Mark for the Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N Nov 20 2014
Mallinckrodt Earnings Beat But No New Guidance Nov 19 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – November 19, 2014 Nov 19 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – November 19, 2014 Nov 19 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – November 19, 2014 Nov 19 2014
Medtronic plans to complete Covidien deal Nov 18 2014
Medtronic profit meets expectations; Covidien deal on track Nov 18 2014
Medtronic profit meets expectations; Covidien deal on track Nov 18 2014
Medtronic Earnings In Line; Sales Guidance Up Nov 18 2014
[$$] Medtronic Revenue Grows 5%, Backs Commitment to Covidien Deal Nov 18 2014
Covidien's Test Data Positive for VenaSeal Closure System Nov 17 2014
COVIDIEN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 17 2014
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 Nov 17 2014
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 Nov 17 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK